lupus erythematosus

(redirected from Cutaneous lupus erythematosus)
Also found in: Thesaurus, Medical, Encyclopedia.

lupus er·y·the·ma·to·sus

 (ĕr′ə-thē′mə-tō′səs, -thĕm′ə-)
n.
2. Any of several other autoimmune disorders typically characterized by reddish, scaly lesions on the skin, especially:
a. A chronic cutaneous form characterized by patchy lesions that form especially on the head and neck, with accompanying scarring and pigmentation changes; discoid lupus erythematosus.
b. A form caused by exposure to a drug and resolving with discontinuance of the drug, characterized by signs and symptoms similar to those of systemic lupus erythematosus; drug-induced lupus erythematosus.

[New Latin lupus erythēmatōsus : lupus + erythēmatōsus, erythematous.]

lupus erythematosus

(ˌɛrɪˌθiːməˈtəʊsəs)
n
(Pathology) either of two inflammatory diseases of the connective tissue. Discoid lupus erythematosus is characterized by a scaly rash over the cheeks and bridge of the nose; disseminated or systemic lupus erythematosus affects the joints, lungs, kidneys, or skin. Abbreviation: LE

lu′pus er•y•the•ma•to′sus

(ˌɛr əˌθi məˈtoʊ səs, -ˌθɛm ə-)
n.
any of several autoimmune diseases, esp. systemic lupus erythematosus, characterized by red, scaly skin patches.
[1855–60; < New Latin]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.lupus erythematosus - a chronic inflammatory collagen disease affecting connective tissue (skin or joints)
autoimmune disease, autoimmune disorder - any of a large group of diseases characterized by abnormal functioning of the immune system that causes your immune system to produce antibodies against your own tissues
lupus - any of several forms of ulcerative skin disease
Translations

lu·pus er·y·the·ma·to·sus

n. lupus eritematoso sistémico, condición caracterizada por episodios febriles que afecta las vísceras y el sistema nervioso;
n. lupus eritematoso discoide, condición caracterizada por placas escamosas de bordes enrojecidos que causa irritación de la piel.
References in periodicals archive ?
Cutaneous lupus erythematosus can be classified into acute, subacute, and chronic lesions.
Since the introduction of direct immunofluorescence, the lupus band test has become an important tool for the diagnosis of cutaneous lupus erythematosus.
But these studies have not provided over-whelming evidence proving the safety of hydroxychloroquine, Jean-Charles Piette, M.D., said at an international conference on cutaneous lupus erythematosus.
Moreover, we and others have published findings showing significant rates of progression of cutaneous lupus erythematosus (CLE) to SLE.
-- Cutaneous lupus erythematosus (CLE) and dermatomyositis look identical on histology, so the diagnosis boils down to the clinical exam.
NEW YORK -- The incidence of subacute cutaneous lupus erythematosus is on the rise because of growing use of drugs that can trigger the disorder.
(Nasdaq: HOTH), a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from dermatological indications ranging from atopic dermatitis to chronic wound disorders, today announced it has entered into a definitive partnership agreement with Zylo Therapeutics to develop a new treatment for patients suffering from Cutaneous Lupus Erythematosus [CLE], a chronic autoimmune disease that affects the skin.
Hoth Therapeutics has entered into a definitive partnership agreement with Zylo Therapeutics to develop a new treatment for patients suffering from Cutaneous Lupus Erythematosus, a chronic autoimmune disease that affects the skin.
Joint and cutaneous disease activity were also assessed with joint counts and Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI), respectively.
Ro/SSA-positive cutaneous lupus erythematosus induced by carbamazepine.
In addition to cutaneous lymphomas, a diagnosis can also be confused with polymorphic light eruption, cutaneous sarcoidosis, cutaneous lupus erythematosus, discoid lupus erythematosus, and lupus tumidus (7).
The company's report, "Global Orphan and Rare Dermatology Drugs Market to 2024," identifies the changing trends in the orphan and rare dermatology drugs market with particular focus on systemic sclerosis (scleroderma), alopecia, epidermolysis bullosa, pemphigus vulgaris, vitiligo and cutaneous lupus erythematosus.

Full browser ?